Cancer Vaccine Therapeutics: Limitations and Effectiveness-A Literature Review
/in Dendritic Cells, International Publications /von 2023-08-28 / Cells 2023 Aug;12(17)A Comprehensive Review on Cancer Vaccines and Vaccine Strategies in Hepatocellular Carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2023-08-12 / Vaccines (Basel) 2023 Aug;11(8)Clinical Applications of Immunotherapy for Recurrent Glioblastoma in Adults
/in Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease Virus /von 2023-07-31 / Cancers (Basel) 2023 Jul;15(15)Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?
/in Dendritic Cells, Glioblastoma, International Publications, IOZK Aktuelles, IOZK Veröffentlichungen /von 2023-07-28 / Transl Cancer Res 2023 Aug;12(8):2224-2228Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors
/in Breast Cancer, Dendritic Cells, International Publications /von 2023-07-15 / J Immunol 2023 Jul;211(2):219-228Potential of Personalized Dendritic Cell-Based Immunohybridoma Vaccines to Treat Prostate Cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2023-07-01 / Life (Basel) 2023 Jul;13(7)A review of the clinical experience with CMN-001, a tumor RNA loaded dendritic cell immunotherapy for the treatment of metastatic renal cell carcinoma
/in Dendritic Cells, Hypernephroma, International Publications /von 2023-06-30 / Hum Vaccin Immunother 2023 Aug;19(2):2220629Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines
/in Dendritic Cells, Glioblastoma, International Publications, Malignant Melanoma /von 2023-05-03 / Hum Vaccin Immunother 2023 May;:2198467Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C
/in Dendritic Cells, Glioblastoma, International Publications /von 2023-04-21 / J Pharm Anal 2023 Jun;13(6):616-624
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de